SEC Filings

Filing Date

Form

Description

Downloads

9/25/15 10-Q Quarterly Report Download SEC Filing to Adobe PDF ico_xbrl
2/24/15 10-Q Quarterly Report Download SEC Filing to Adobe PDF  ico_xbrl
11/19/2014 10-Q Quarterly Report Download SEC Filing to Adobe PDF ico_xbrl
09/22/14 S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Download SEC Filing to Word Download SEC Filing to Adobe PDF  ico_xbrl
08/13/14 NT 10-Q Notification that Quarterly Report will be submitted late Download SEC Filing to Word Download SEC Filing to Adobe PDF  ico_xbrl
07/11/14 10-K Annual Report Download SEC Filing to Word Download SEC Filing to Adobe PDF  ico_xbrl
02/19/14 10-Q Quarterly report [Sections 13 or 15(d)] Acc-no: 0001255294-14-000095(34 Act) Download SEC Filing to Word Download SEC Filing to Adobe PDF ico_xbrl
11/19/13 10-Q Quarterly report [Sections 13 or 15(d)] Acc-no: 0001255294-13-000937 (34 Act) Download SEC Filing to Word Download SEC Filing to Adobe PDF ico_xbrl
08/19/13 10-Q Quarterly report [Sections 13 or 15(d)] Acc-no: 0001255294-13-000668 (34 Act) Download SEC Filing to Word Download SEC Filing to Adobe PDF ico_xbrl
07/01/13 10K 2013  Annual Report 2013 ico_xbrl

News

December 5th, 2017

Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical Trials
View Release

July 18th, 2017

Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson’s Disease: Company Will Receive Cash and Stock and Plans to Pay One Third of the Shares Received in a Dividend to Shareholders
View Release

June 21st, 2017

Rich Pharmaceuticals Announces Principal Doctor for Clinical Trials
View Release

» View All News

Stock Price